Mutant RNF43 almost exclusively occurs along with abnormal KRAS (Figure 6) and therefore, KRAS mutation is likely required for RNF43 mutation‐associated pancreatic cancer development. This evidence concerns the gene KRAS and familial pancreatic carcinoma.